期刊文献+

The crosstalk between autophagy and ferroptosis:what can we learn to target drug resistance in cancer? 被引量:9

The crosstalk between autophagy and ferroptosis:what can we learn to target drug resistance in cancer?
下载PDF
导出
摘要 Autophagy is a conserved intracellular degradation system that plays a dual role in cell death;thus,therapies targeting autophagy in cancer are somewhat controversial.Ferroptosis is a new form of regulated cell death featured with the iron-dependent accumulation of lethal lipid ROS.This pathway is morphologically,biochemically and genetically distinct from other forms of cell death.Accumulating studies have revealed crosstalk between autophagy and ferroptosis at the molecular level.In this review,we summarize the mechanisms of ferroptosis and autophagy,and more importantly,their roles in the drug resistance of cancer.Numerous connections between ferroptosis and autophagy have been revealed,and a strong causal relationship exists wherein one process controls the other and can be utilized as potential therapeutic targets for cancer.The elucidation of when and how to modulate their crosstalk using therapeutic strategies depends on an understanding of the fine-tuned switch between ferroptosis and autophagy,and approaches designed to manipulate the intensity of autophagy might be the key. Autophagy is a conserved intracellular degradation system that plays a dual role in cell death; thus, therapies targeting autophagy in cancer are somewhat controversial. Ferroptosis is a new form of regulated cell death featured with the iron-dependent accumulation of lethal lipid ROS. This pathway is morphologically, biochemically and genetically distinct from other forms of cell death. Accumulating studies have revealed crosstalk between autophagy and ferroptosis at the molecular level. In this review, we summarize the mechanisms of ferroptosis and autophagy, and more importantly, their roles in the drug resistance of cancer.Numerous connections between ferroptosis and autophagy have been revealed, and a strong causal relationship exists wherein one process controls the other and can be utilized as potential therapeutic targets for cancer. The elucidation of when and how to modulate their crosstalk using therapeutic strategies depends on an understanding of the fine-tuned switch between ferroptosis and autophagy, and approaches designed to manipulate the intensity of autophagy might be the key.
出处 《Cancer Biology & Medicine》 SCIE CAS CSCD 2019年第4期630-646,共17页 癌症生物学与医学(英文版)
基金 supported by the National Natural Science Foundation of China (Grant No. 81602471, 81672729, 81672729, 81874380 and 81672932) Zhejiang Provincial Natural Science Foundation of China under Grants (Grant No. LY19H160055, LY19H160059) by Zheng Shu Medical Elite Scholarship Fund by grant from sub-project of China National Program on Key Basic Research Project (973 Program) (Grant No. 2014CB744505) Zhejiang Provincial Natural Science Foundation of China for Distinguished Young Scholars (Grant No. LR18H160001) Zhejiang Province Medical Science and Technology Project (Grant No. 2017RC007) Talent Project of Zhejiang Association for Science and Technology (Grant No. 2017YCGC002) Zhejiang Province Science and Technology Project of TCM (Grant No. 2019ZZ016)
关键词 AUTOPHAGY ferroptosis CROSSTALK CANCER drug resistance Autophagy ferroptosis crosstalk cancer drug resistance
  • 相关文献

参考文献1

共引文献82

同被引文献48

引证文献9

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部